General Information of the Cell Line
Cell Line ID
CL000145
Cell Line Name
NCI-H460
Synonyms
NCI.H460
H460
H-460
NCIH460
NCI-HUT-460
NCI-460
Category
Cancer cell line
Organism
Homo sapiens (Human)
Cellosaurus ID
CVCL_0459
Tissue Information
Pleural effusion
Disease
Lung large cell carcinoma (NCIt: C4450)
Map of Molecular Bioactivity Related to the Cell Line
Map of Molecular Bioactivity Related to the Cell Line

Cell Line
Protein
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Cell Line
Protein ID: PT02718, ATP-binding cassette sub-family G member 2
Compound ID Compound Name Compound Formula
CP0386291
5-[(4-bromophenyl)methoxy]-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-4-oxochromene-2-carboxamide
   Show/Hide
C28H23BrN2O5
 1
1
EC50 = 50 nM
   TI
   LI
   LO
   TS
CP0141589
3-((3S,6S)-6-Isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydro-pyrazino[1',2':1,6]pyrido[3,4-b]indol-3-yl)-propionic acid tert-butyl ester
   Show/Hide
C26H35N3O5
 1
1
EC50 = 70 nM
   TI
   LI
   LO
   TS
CP0390183
5-[(4-bromophenyl)methoxy]-N-[2-(6-methoxy-1H-indol-3-yl)ethyl]-4-oxochromene-2-carboxamide
   Show/Hide
C28H23BrN2O5
 1
1
EC50 = 80 nM
   TI
   LI
   LO
   TS
CP0390181
6-[(4-bromophenyl)methoxy]-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-4-oxochromene-2-carboxamide
   Show/Hide
C28H23BrN2O5
 1
1
EC50 = 100 nM
   TI
   LI
   LO
   TS
CP0420730
5-[(4-bromophenyl)methoxy]-N-[2-(1-methylindol-3-yl)ethyl]-4-oxochromene-2-carboxamide
   Show/Hide
C28H23BrN2O4
 1
1
EC50 = 220 nM
   TI
   LI
   LO
   TS
CP0420732
5-[(4-bromophenyl)methoxy]-N-[[1-[2-(1H-indol-3-yl)ethyl]triazol-4-yl]methyl]-4-oxochromene-2-carboxamide
   Show/Hide
C30H24BrN5O4
 1
1
EC50 = 460 nM
   TI
   LI
   LO
   TS
CP0390179
N-[(1-benzyltriazol-4-yl)methyl]-5-[(4-bromophenyl)methoxy]-4-oxochromene-2-carboxamide
   Show/Hide
C27H21BrN4O4
 1
1
EC50 = 500 nM
   TI
   LI
   LO
   TS
CP0390180
5-[(4-bromophenyl)methoxy]-N-methyl-N-[2-(1-methylindol-3-yl)ethyl]-4-oxochromene-2-carboxamide
   Show/Hide
C29H25BrN2O4
 1
1
EC50 = 500 nM
   TI
   LI
   LO
   TS
CP0390177
5-[(4-bromophenyl)methoxy]-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-methyl-4-oxochromene-2-carboxamide
   Show/Hide
C29H25BrN2O5
 1
1
EC50 = 530 nM
   TI
   LI
   LO
   TS
CP0396056
5-[(4-bromophenyl)methoxy]-N-[2-(1H-indol-3-yl)ethyl]-N-methyl-4-oxochromene-2-carboxamide
   Show/Hide
C28H23BrN2O4
 1
1
EC50 = 570 nM
   TI
   LI
   LO
   TS
CP0420731
5-[(4-bromophenyl)methoxy]-2-[[2-(5-methoxy-1H-indol-3-yl)ethyl-methylamino]methyl]chromen-4-one
   Show/Hide
C29H27BrN2O4
 1
1
EC50 = 600 nM
   TI
   LI
   LO
   TS
CP0390178
5-[(4-bromophenyl)methoxy]-N-[[1-[(4-bromophenyl)methyl]triazol-4-yl]methyl]-4-oxochromene-2-carboxamide
   Show/Hide
C27H20Br2N4O4
 1
1
EC50 = 710 nM
   TI
   LI
   LO
   TS
CP0853055
N-((5-(4-bromobenzyloxy)-4-oxo-4H-chromen-2-yl)methyl)-2-(1H-indol-3-yl)-N-methylethanaminium chloride
   Show/Hide
C28H26BrClN2O3
 1
1
EC50 = 1110 nM
   TI
   LI
   LO
   TS
CP0426168
7-[(4-bromophenyl)methoxy]-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-4-oxochromene-2-carboxamide
   Show/Hide
C28H23BrN2O5
 1
1
EC50 = 1540 nM
   TI
   LI
   LO
   TS
CP0420729
6-[(4-bromophenyl)methoxy]-N-[2-(1H-indol-3-yl)ethyl]-N-methyl-4-oxochromene-2-carboxamide
   Show/Hide
C28H23BrN2O4
 1
1
EC50 = 1670 nM
   TI
   LI
   LO
   TS
CP0432272
6-[(4-bromophenyl)methoxy]-N-methyl-N-[2-(1-methylindol-3-yl)ethyl]-4-oxochromene-2-carboxamide
   Show/Hide
C29H25BrN2O4
 1
1
EC50 = 2150 nM
   TI
   LI
   LO
   TS
CP0046870
FTC
   Show/Hide
C22H25N3O3
 1
1
IC50 = 800 nM
   TI
   LI
   LO
   TS
CP0450628
(2S)-5,7-dihydroxy-2-(4-hydroxyphenyl)-8-(3-methylbut-2-en-1-yl)-3,4-dihydro-2H-1-benzopyran-4-one
   Show/Hide
C20H20O5
 1
1
IC50 = 3100 nM
   TI
   LI
   LO
   TS
CP0477981
(S)-2-(3,5-dihydroxyphenyl)-5,7-dihydroxy-6,8-bis(3-methylbut-2-enyl)chroman-4-one
   Show/Hide
C25H28O6
 1
1
IC50 = 4100 nM
   TI
   LI
   LO
   TS
CP0049981
3',5-dihydroxy-3,4',7-trimethoxyflavone
   Show/Hide
C18H16O7
 1
1
IC50 = 5700 nM
   TI
   LI
   LO
   TS
CP0477982
6-(3,7-dimethylocta-2,6-dienyl)-3,5,7-trihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one
   Show/Hide
C25H26O6
 1
1
IC50 = 5700 nM
   TI
   LI
   LO
   TS
CP0377198
8-hydroxy-5,10-dimethoxy-2-propyl-4H-benzo[h]chromen-4-one
   Show/Hide
C18H18O5
 1
1
IC50 = 5900 nM
   TI
   LI
   LO
   TS
CP0489184
5-Hydroxy-3-(4-hydroxy-3-methyl-but-2-enyl)-8,8-dimethyl-2-(2,4,5-trihydroxy-phenyl)-8H-pyrano[2,3-f]chromen-4-one
   Show/Hide
C25H24O8
 1
1
IC50 = 6500 nM
   TI
   LI
   LO
   TS
CP0471347
(2S)-5,7,3'-trihydroxy-4'-methoxy-8-(3''-methylbut-2''-enyl)-flavonone
   Show/Hide
C21H22O6
 1
1
IC50 = 6600 nM
   TI
   LI
   LO
   TS
CP0923331
5,7,3'-trihydroxy-3,5'-dimethoxy-2'-(3'-methylbut-2-enyl)flavone
   Show/Hide
C22H22O7
 1
1
IC50 = 8400 nM
   TI
   LI
   LO
   TS
CP0010754
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-chromen-4-one
   Show/Hide
C15H10O6
 1
1
IC50 = 8900 nM
   TI
   LI
   LO
   TS
CP0514214
4,5-dihydroxy-10-methoxy-2-propylbenzo[h]chromen-8-one
   Show/Hide
C17H16O5
 1
1
IC50 = 9000 nM
   TI
   LI
   LO
   TS
CP0406022
5,8-dihydroxy-6,10-dimethoxy-2-methyl-4H-benzo[h]chromen-4-one
   Show/Hide
C16H14O6
 1
1
IC50 = 11900 nM
   TI
   LI
   LO
   TS
CP0477983
(S)-8-(3,7-dimethylocta-2,6-dienyl)-5,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-one
   Show/Hide
C25H28O5
 1
1
IC50 = 12300 nM
   TI
   LI
   LO
   TS
CP0504448
5,8-dihydroxy-10-methoxy-2-methyl-4H-benzo[h]chromen-4-one
   Show/Hide
C15H12O5
 1
1
IC50 = 12800 nM
   TI
   LI
   LO
   TS
CP0377976
(2S)-5,7,3',5'-tetrahydroxy-8-[3'',8''-dimethylocta-2''(E),7''-dienyl]flavonone
   Show/Hide
C25H28O6
 1
1
IC50 = 15500 nM
   TI
   LI
   LO
   TS
CP0156876
6-methoxycomaparvin 5-methyl ether
   Show/Hide
C19H20O6
 1
1
IC50 = 16600 nM
   TI
   LI
   LO
   TS
CP0471348
5,4'-dihydroxy-3,7,3'-trimethoxyflavone
   Show/Hide
C18H16O7
 1
1
IC50 = 17200 nM
   TI
   LI
   LO
   TS
CP0310421
6-methoxycomaparvin
   Show/Hide
C18H18O6
 1
1
IC50 > 20000 nM
   TI
   LI
   LO
   TS
CP0503265
(2S)-5,7-dihydroxy-4'-methoxy-8-prenylflavanone
   Show/Hide
C21H22O5
 1
1
IC50 = 22600 nM
   TI
   LI
   LO
   TS
Cell Viability or Cytotoxicity Assay
Compound ID Compound Name Compound Formula
CP0003433
(Arylindolyl)maleimide deriv. 27
   Show/Hide
C21H16N4O2  2
1
GI50 = 3800 nM
   TI
   LI
   LO
   TS
2
LC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0003676
N-hydroxy-2-[[2-(6-methoxypyridin-3-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl-methylamino]pyrimidine-5-carboxamide
   Show/Hide
C23H24N8O4S  1
1
IC50 = 150 nM
   TI
   LI
   LO
   TS
CP0003832
N'-hydroxy-N-phenyloctanediamide
   Show/Hide
C14H20N2O3  2
1
IC50 = 1200 nM
   TI
   LI
   LO
   TS
2
IC50 = 3400 nM
   TI
   LI
   LO
   TS
CP0007430
IBRUTINIB
   Show/Hide
C25H24N6O2  1
1
GI50 > 10000 nM
   TI
   LI
   LO
   TS
CP0007711
(E)-3-[4-[[2-(2-methyl-1H-indol-3-yl)ethylamino]methyl]phenyl]-N'-propylprop-2-enehydrazide;2,2,2-trifluoroacetic acid
   Show/Hide
C26H31F3N4O3  1
1
GI50 = 163 nM
   TI
   LI
   LO
   TS
CP0015055
N-[5-[2-amino-4-methyl-8-(oxan-4-yloxy)quinazolin-6-yl]-2-methoxypyridin-3-yl]-2,4-difluorobenzenesulfonamide
   Show/Hide
C26H25F2N5O5S  1
1
IC50 = 29 nM
   TI
   LI
   LO
   TS
CP0017774
4-[[7-[2,6-bis(fluoranyl)phenyl]-9-chloranyl-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]benzoic acid
   Show/Hide
C25H15ClF2N4O2  1
1
IC50 = 110 nM
   TI
   LI
   LO
   TS
CP0042443
(S)-1-(5-phenyl-3-(piperidin-3-ylcarbamoyl)thiophen-2-yl)urea
   Show/Hide
C17H20N4O2S  1
1
GI50 = 1231 nM
   TI
   LI
   LO
   TS
CP0046554
6-[difluoro-[6-(4-fluorophenyl)-[1,2,4]triazolo[4,3-b][1,2,4]triazin-3-yl]methyl]quinoline
   Show/Hide
C20H11F3N6  1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0046870
FTC
   Show/Hide
C22H25N3O3  1
1
IC50 = 186 nM
   TI
   LI
   LO
   TS
CP0053637
(S)-N-(4-(3-chloro-4-fluorophenylamino)-7-(tetrahydrofuran-3-yloxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide
   Show/Hide
C24H25ClFN5O3  1
1
IC50 = 6140 nM
   TI
   LI
   LO
   TS
CP0058788
(E)-N-hydroxy-3-[4-(4-methoxyphenyl)phenyl]prop-2-enamide
   Show/Hide
C16H15NO3  1
1
IC50 = 3700 nM
   TI
   LI
   LO
   TS
CP0060320
(2E,4E)-N-hydroxy-5-[4-(4-methoxyphenyl)phenyl]penta-2,4-dienamide
   Show/Hide
C18H17NO3  1
1
IC50 > 20000 nM
   TI
   LI
   LO
   TS
CP0060330
(E)-N-hydroxy-3-[4-(4-hydroxyphenyl)phenyl]prop-2-enamide
   Show/Hide
C15H13NO3  1
1
IC50 = 6000 nM
   TI
   LI
   LO
   TS
CP0064592
[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate
   Show/Hide
C47H51NO14  1
1
GI50 = 6.3 nM
   TI
   LI
   LO
   TS
CP0070522
(E)-3-(4-hydroxy-2-methoxy-5-(2-methylbut-3-en-2-yl)phenyl)-1-(4-hydroxyphenyl)prop-2-en-1-one
   Show/Hide
C21H22O4  1
1
IC50 = 10000 nM
   TI
   LI
   LO
   TS
CP0079521
1-N'-[3-fluoro-4-[6-(2-hydroxy-3-morpholin-4-ylpropoxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-4-yl]oxyphenyl]-1-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
   Show/Hide
C31H32F2N6O6  1
1
IC50 >= 50 nM
   TI
   LI
   LO
   TS
CP0085832
(1R,4S,7Z,10S,16E,21R)-7-ethylidene-4,21-di(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetrazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone
   Show/Hide
C24H36N4O6S2  1
1
GI50 = 3 nM
   TI
   LI
   LO
   TS
CP0086044
(E)-N-hydroxy-3-(4-phenylphenyl)prop-2-enamide
   Show/Hide
C15H13NO2  1
1
IC50 = 5400 nM
   TI
   LI
   LO
   TS
CP0151685
N-(2-aminophenyl)-4-[[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]anilino]methyl]benzamide
   Show/Hide
C30H27N7O  2
1
IC50 = 2510 nM
   TI
   LI
   LO
   TS
2
IC50 = 2511.89 nM
   TI
   LI
   LO
   TS
CP0166540
N-benzyl-2-[5-[4-(2-morpholin-4-ylethoxy)phenyl]pyridin-2-yl]acetamide
   Show/Hide
C26H29N3O3  1
1
GI50 = 51 nM
   TI
   LI
   LO
   TS
CP0176598
N-[4-[2-[(2S,3S,5R)-2-[[tert-butyl(dimethyl)silyl]oxymethyl]-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]-1,3-dithian-2-yl]phenyl]-N'-hydroxyoctanediamide
   Show/Hide
C34H52N4O7S2Si  1
1
GI50 = 3981.07 nM
   TI
   LI
   LO
   TS
CP0204175
(E)-N-hydroxy-3-[3-(4-hydroxyphenyl)phenyl]prop-2-enamide
   Show/Hide
C15H13NO3  1
1
IC50 = 5600 nM
   TI
   LI
   LO
   TS
CP0204863
(E)-N-hydroxy-3-(4-((4-methyl-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)phenylamino)methyl)phenyl)acrylamide
   Show/Hide
C26H24N6O2  1
1
IC50 = 1995.26 nM
   TI
   LI
   LO
   TS
CP0227790
4-(4-chlorophenyl)-6-(3-methoxypiperidin-1-yl)-N-[3-[2-(4-methylpiperazin-1-yl)ethoxy]phenyl]pyrimidin-2-amine
   Show/Hide
C29H37ClN6O2  1
1
GI50 = 600 nM
   TI
   LI
   LO
   TS
CP0245716
N-hydroxy-3-[4-(4-hydroxyphenyl)phenyl]propanamide
   Show/Hide
C15H15NO3  1
1
IC50 = 15200 nM
   TI
   LI
   LO
   TS
CP0252512
1-N'-[3-fluoro-4-[5-methyl-6-(3-methylsulfonylpropoxy)pyrrolo[2,1-f][1,2,4]triazin-4-yl]oxyphenyl]-1-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
   Show/Hide
C28H27F2N5O6S  1
1
IC50 >= 50 nM
   TI
   LI
   LO
   TS
CP0298640
(Z)-1-[2-Oxo-3-(1H-pyrrol-2-ylmethylene)-2,3-dihydro-1H-indol-6-yl]-3-phenyl-urea
   Show/Hide
C20H16N4O2  1
1
IC50 = 3280 nM
   TI
   LI
   LO
   TS
CP0302610
N-cyclopropyl-4-[8-(oxan-4-ylmethylamino)-6-[(1,1,1-trifluoro-2-methylpropan-2-yl)amino]imidazo[1,2-b]pyridazin-3-yl]benzamide
   Show/Hide
C26H31F3N6O2  1
1
IC50 = 10 nM
   TI
   LI
   LO
   TS
CP0370065
5-(4-chlorophenyl)-2-(4-methoxyphenyl)-[1,3]thiazolo[3,2-b][1,2,4]triazole
   Show/Hide
C17H12ClN3OS  2
1
GI50 = 1330 nM
   TI
   LI
   LO
   TS
2
LC50 = 18900 nM
   TI
   LI
   LO
   TS
CP0383276
N-(4-methoxyphenyl)-N,2,6-trimethylfuro[2,3-d]pyrimidin-4-amine
   Show/Hide
C16H17N3O2  1
1
GI50 = 33.1 nM
   TI
   LI
   LO
   TS
CP0383415
N-[2-methyl-5-(2-oxo-9-pyrazol-1-ylbenzo[h][1,6]naphthyridin-1-yl)phenyl]propanamide
   Show/Hide
C25H21N5O2  1
1
GI50 > 10000 nM
   TI
   LI
   LO
   TS
CP0387825
(E)-N-hydroxy-3-[4-[4-(hydroxymethyl)phenyl]phenyl]prop-2-enamide
   Show/Hide
C16H15NO3  1
1
IC50 = 3800 nM
   TI
   LI
   LO
   TS
CP0390499
N-[2-[2-(3-methoxyphenyl)tetrazol-5-yl]phenyl]-4-nitrobenzamide
   Show/Hide
C21H16N6O4  2
1
IC50 = 240 nM
   TI
   LI
   LO
   TS
2
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0408097
(1R,4aS,10aR)-N-[(2S)-1-(3-bromoanilino)-1-oxo-3-phenylpropan-2-yl]-6-[[(2S)-1-(3-bromoanilino)-1-oxo-3-phenylpropan-2-yl]sulfamoyl]-1,4a-dimethyl-7-propan-2-yl-2,3,4,9,10,10a-hexahydrophenanthrene-1-carboxamide
   Show/Hide
C50H54Br2N4O5S  1
1
IC50 = 39900 nM
   TI
   LI
   LO
   TS
CP0408099
(4bS,8R,8aR)-8-[[(2R)-1-(2-fluoroanilino)-1-oxo-3-phenylpropan-2-yl]carbamoyl]-4b,8-dimethyl-2-propan-2-yl-5,6,7,8a,9,10-hexahydrophenanthrene-3-sulfonic acid
   Show/Hide
C35H41FN2O5S  1
1
IC50 > 50000 nM
   TI
   LI
   LO
   TS
CP0408101
(1R,4aS,10aR)-1,4a-dimethyl-N-[(2S)-1-(3-methylanilino)-1-oxo-3-phenylpropan-2-yl]-6-[[(2S)-1-(3-methylanilino)-1-oxo-3-phenylpropan-2-yl]sulfamoyl]-7-propan-2-yl-2,3,4,9,10,10a-hexahydrophenanthrene-1-carboxamide
   Show/Hide
C52H60N4O5S  1
1
IC50 = 10600 nM
   TI
   LI
   LO
   TS
CP0412740
4-methoxy-N-[2-[2-(4-methoxyphenyl)tetrazol-5-yl]phenyl]benzamide
   Show/Hide
C22H19N5O3  3
1
IC50 = 149 nM
   TI
   LI
   LO
   TS
2
IC50 = 156 nM
   TI
   LI
   LO
   TS
3
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0416771
[(8R,9S,10R,13R,14R,15S,17S)-15-acetyloxy-17-[(1S)-1-[(2R)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]-1-hydroxyethyl]-14,17-dihydroxy-10-methyl-1-oxo-4,7,8,9,11,12,15,16-octahydrocyclopenta[a]phenanthren-13-yl]methyl acetate
   Show/Hide
C32H42O10  1
1
IC50 = 2000 nM
   TI
   LI
   LO
   TS
CP0421570
N-(5-methoxynaphthalen-2-yl)-N,2-dimethyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-amine
   Show/Hide
C20H21N3O  1
1
GI50 < 10 nM
   TI
   LI
   LO
   TS
CP0422898
(1R,4aS,10aR)-N-[(2S)-1-anilino-1-oxo-3-phenylpropan-2-yl]-6-[[(2S)-1-anilino-1-oxo-3-phenylpropan-2-yl]sulfamoyl]-1,4a-dimethyl-7-propan-2-yl-2,3,4,9,10,10a-hexahydrophenanthrene-1-carboxamide
   Show/Hide
C50H56N4O5S  1
1
IC50 = 17500 nM
   TI
   LI
   LO
   TS
CP0425261
N-(1-benzofuran-5-yl)-N,2,6-trimethylfuro[2,3-d]pyrimidin-4-amine
   Show/Hide
C17H15N3O2  1
1
GI50 = 138 nM
   TI
   LI
   LO
   TS
CP0427230
(1R,4aS,10aR)-1,4a-dimethyl-N-[(2R)-1-(2-methylanilino)-1-oxo-3-phenylpropan-2-yl]-6-[[(2R)-1-(2-methylanilino)-1-oxo-3-phenylpropan-2-yl]sulfamoyl]-7-propan-2-yl-2,3,4,9,10,10a-hexahydrophenanthrene-1-carboxamide
   Show/Hide
C52H60N4O5S  1
1
IC50 = 30700 nM
   TI
   LI
   LO
   TS
CP0428396
(E)-3-[4-(3-chloro-4-hydroxyphenyl)phenyl]-N-hydroxyprop-2-enamide
   Show/Hide
C15H12ClNO3  1
1
IC50 = 3100 nM
   TI
   LI
   LO
   TS
CP0430065
2-[(4-nitrophenyl)carbamoylamino]-N-(4-propylphenyl)benzamide
   Show/Hide
C23H22N4O4  1
1
IC50 = 211 nM
   TI
   LI
   LO
   TS
CP0430066
2-[(3-nitrophenyl)carbamoylamino]-N-(4-propylphenyl)benzamide
   Show/Hide
C23H22N4O4  2
1
IC50 = 201 nM
   TI
   LI
   LO
   TS
2
IC50 = 205 nM
   TI
   LI
   LO
   TS
CP0435299
(1R,4aS,10aR)-N-[(2S)-1-(2-fluoroanilino)-1-oxo-3-phenylpropan-2-yl]-6-[[(2S)-1-(2-fluoroanilino)-1-oxo-3-phenylpropan-2-yl]sulfamoyl]-1,4a-dimethyl-7-propan-2-yl-2,3,4,9,10,10a-hexahydrophenanthrene-1-carboxamide
   Show/Hide
C50H54F2N4O5S  1
1
IC50 = 43900 nM
   TI
   LI
   LO
   TS
CP0435300
(4bS,8R,8aR)-8-[[(2R)-1-(2-bromoanilino)-1-oxo-3-phenylpropan-2-yl]carbamoyl]-4b,8-dimethyl-2-propan-2-yl-5,6,7,8a,9,10-hexahydrophenanthrene-3-sulfonic acid
   Show/Hide
C35H41BrN2O5S  1
1
IC50 > 50000 nM
   TI
   LI
   LO
   TS
CP0440195
1-N'-[3-fluoro-4-[5-methyl-6-(3-morpholin-4-ylpropylcarbamoyl)pyrrolo[2,1-f][1,2,4]triazin-4-yl]oxyphenyl]-1-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
   Show/Hide
C32H33F2N7O5  1
1
IC50 >= 50 nM
   TI
   LI
   LO
   TS
CP0446609
4-amino-N-[2-[2-(3-methoxyphenyl)tetrazol-5-yl]phenyl]benzamide
   Show/Hide
C21H18N6O2  2
1
IC50 = 217 nM
   TI
   LI
   LO
   TS
2
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0446610
1-(4-azidophenyl)-3-[2-[2-(3-methoxyphenyl)tetrazol-5-yl]phenyl]urea
   Show/Hide
C21H17N9O2  2
1
IC50 = 279 nM
   TI
   LI
   LO
   TS
2
IC50 = 281 nM
   TI
   LI
   LO
   TS
CP0446611
1-(4-aminophenyl)-3-[2-[2-(3-methoxyphenyl)tetrazol-5-yl]phenyl]urea
   Show/Hide
C21H19N7O2  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0446612
1-[2-[2-(4-methoxyphenyl)tetrazol-5-yl]phenyl]-3-(4-nitrophenyl)urea
   Show/Hide
C21H17N7O4  2
1
IC50 = 122 nM
   TI
   LI
   LO
   TS
2
IC50 = 174 nM
   TI
   LI
   LO
   TS
CP0446664
2-[(4-nitrobenzoyl)amino]-N-(4-propylphenyl)benzamide
   Show/Hide
C23H21N3O4  2
1
IC50 = 212 nM
   TI
   LI
   LO
   TS
2
IC50 = 213 nM
   TI
   LI
   LO
   TS
CP0448194
N-[2-[2-(4-methoxyphenyl)tetrazol-5-yl]phenyl]-4-nitrobenzamide
   Show/Hide
C21H16N6O4  2
1
IC50 = 143 nM
   TI
   LI
   LO
   TS
2
IC50 = 24730 nM
   TI
   LI
   LO
   TS
CP0451686
2-(3-benzyl-5-chloro-1H-indol-2-yl)acetamide
   Show/Hide
C17H15ClN2O  1
1
IC50 = 34000 nM
   TI
   LI
   LO
   TS
CP0455168
6-methyl-N-[4-[(E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]phenyl]thieno[2,3-b]quinoline-2-carboxamide
   Show/Hide
C31H26N2O5S  1
1
IC50 = 3200 nM
   TI
   LI
   LO
   TS
CP0468829
N-[2-[2-(3-methoxyphenyl)tetrazol-5-yl]phenyl]-2-nitrobenzamide
   Show/Hide
C21H16N6O4  2
1
IC50 = 501 nM
   TI
   LI
   LO
   TS
2
IC50 = 38900 nM
   TI
   LI
   LO
   TS
CP0468831
2-[(3-nitrobenzoyl)amino]-N-(4-propylphenyl)benzamide
   Show/Hide
C23H21N3O4  2
1
IC50 = 205 nM
   TI
   LI
   LO
   TS
2
IC50 = 211 nM
   TI
   LI
   LO
   TS
CP0468833
2-[(2-nitrobenzoyl)amino]-N-(3-propylphenyl)benzamide
   Show/Hide
C23H21N3O4  3
1
IC50 = 206 nM
   TI
   LI
   LO
   TS
2
IC50 = 215 nM
   TI
   LI
   LO
   TS
3
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0468835
4-isothiocyanato-N-[2-[2-(3-methoxyphenyl)tetrazol-5-yl]phenyl]benzamide
   Show/Hide
C22H16N6O2S  2
1
IC50 = 352 nM
   TI
   LI
   LO
   TS
2
IC50 = 457 nM
   TI
   LI
   LO
   TS
CP0468837
1-(4-isothiocyanatophenyl)-3-[2-[2-(3-methoxyphenyl)tetrazol-5-yl]phenyl]urea
   Show/Hide
C22H17N7O2S  2
1
IC50 = 217 nM
   TI
   LI
   LO
   TS
2
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0475569
[(1R)-1-(5,8-dihydroxy-1,4-dioxonaphthalen-2-yl)-4-methylpent-3-enyl] (Z)-4-(2,5-dimethylphenyl)-4-oxobut-2-enoate
   Show/Hide
C28H26O7  1
1
IC50 = 13210 nM
   TI
   LI
   LO
   TS
CP0476016
1-[4-[1-adamantyl(phenyl)methyl]phenyl]piperazine
   Show/Hide
C27H34N2  2
1
GI50 = 3740 nM
   TI
   LI
   LO
   TS
2
LC50 = 9700 nM
   TI
   LI
   LO
   TS
CP0476031
4-[4-[1-adamantyl(phenyl)methyl]phenyl]morpholine
   Show/Hide
C27H33NO  1
1
LC50 = 100000 nM
   TI
   LI
   LO
   TS
CP0481548
1-(4-methoxyphenyl)-3-[2-[2-(4-methoxyphenyl)tetrazol-5-yl]phenyl]urea
   Show/Hide
C22H20N6O3  2
1
IC50 = 229 nM
   TI
   LI
   LO
   TS
2
IC50 = 52540 nM
   TI
   LI
   LO
   TS
CP0485196
1-tert-butyl-3-(1-methylindol-3-yl)pyrazolo[3,4-d]pyrimidin-4-amine
   Show/Hide
C18H20N6  1
1
IC50 = 73900 nM
   TI
   LI
   LO
   TS
CP0494024
1-[2-[2-(3-methoxyphenyl)tetrazol-5-yl]phenyl]-3-(3-nitrophenyl)urea
   Show/Hide
C21H17N7O4  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0495109
2-[(4-nitrophenyl)carbamoylamino]-N-[4-(trifluoromethyl)phenyl]benzamide
   Show/Hide
C21H15F3N4O4  3
1
IC50 = 217 nM
   TI
   LI
   LO
   TS
2
IC50 = 222 nM
   TI
   LI
   LO
   TS
3
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0495111
N-[2-[2-(3-methoxyphenyl)tetrazol-5-yl]phenyl]-3-nitrobenzamide
   Show/Hide
C21H16N6O4  2
1
IC50 = 345 nM
   TI
   LI
   LO
   TS
2
IC50 = 19850 nM
   TI
   LI
   LO
   TS
CP0516022
(1R,4aS,10aR)-N-[(2R)-1-(4-methoxyanilino)-1-oxo-3-phenylpropan-2-yl]-6-[[(2R)-1-(4-methoxyanilino)-1-oxo-3-phenylpropan-2-yl]sulfamoyl]-1,4a-dimethyl-7-propan-2-yl-2,3,4,9,10,10a-hexahydrophenanthrene-1-carboxamide
   Show/Hide
C52H60N4O7S  1
1
IC50 = 28900 nM
   TI
   LI
   LO
   TS
CP0517983
N-[4-[2-[(2S,3S,5S)-2-[[tert-butyl(dimethyl)silyl]oxymethyl]-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]-1,3-dithian-2-yl]phenyl]-N'-hydroxyoctanediamide
   Show/Hide
C34H52N4O7S2Si  1
1
GI50 = 4677.35 nM
   TI
   LI
   LO
   TS
CP0518817
1-[2-[2-(3-methoxyphenyl)tetrazol-5-yl]phenyl]-3-(4-nitrophenyl)urea
   Show/Hide
C21H17N7O4  2
1
IC50 = 113 nM
   TI
   LI
   LO
   TS
2
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0518850
2-[(4-methoxyphenyl)carbamoylamino]-N-(4-propylphenyl)benzamide
   Show/Hide
C24H25N3O3  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0518862
2-[(4-bromophenyl)carbamoylamino]-N-(4-propylphenyl)benzamide
   Show/Hide
C23H22BrN3O2  2
1
IC50 = 214 nM
   TI
   LI
   LO
   TS
2
IC50 = 217 nM
   TI
   LI
   LO
   TS
CP0520020
4-[(2-bromoacetyl)amino]-N-[2-[2-(3-methoxyphenyl)tetrazol-5-yl]phenyl]benzamide
   Show/Hide
C23H19BrN6O3  1
1
IC50 = 175 nM
   TI
   LI
   LO
   TS
CP0520167
N-[2-[2-(3-methoxyphenyl)tetrazol-5-yl]phenyl]-4-propylbenzamide
   Show/Hide
C24H23N5O2  2
1
IC50 = 121 nM
   TI
   LI
   LO
   TS
2
IC50 = 26970 nM
   TI
   LI
   LO
   TS
CP0520168
2-[(4-methoxybenzoyl)amino]-N-(4-propylphenyl)benzamide
   Show/Hide
C24H24N2O3  2
1
IC50 = 209 nM
   TI
   LI
   LO
   TS
2
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0520788
(1R,4aS,10aR)-N-[(2R)-1-(3-bromoanilino)-1-oxo-3-phenylpropan-2-yl]-6-[[(2R)-1-(3-bromoanilino)-1-oxo-3-phenylpropan-2-yl]sulfamoyl]-1,4a-dimethyl-7-propan-2-yl-2,3,4,9,10,10a-hexahydrophenanthrene-1-carboxamide
   Show/Hide
C50H54Br2N4O5S  1
1
IC50 > 50000 nM
   TI
   LI
   LO
   TS
CP0524982
1-[4-[1-adamantyl(phenyl)methyl]phenyl]-4-methylpiperazine
   Show/Hide
C28H36N2  2
1
GI50 = 4410 nM
   TI
   LI
   LO
   TS
2
LC50 = 100000 nM
   TI
   LI
   LO
   TS
CP0524983
1-[4-[1-adamantyl(phenyl)methyl]phenyl]-4-benzylpiperazine
   Show/Hide
C34H40N2  1
1
GI50 = 54740 nM
   TI
   LI
   LO
   TS
CP0536379
[(1R)-1-(5,8-dihydroxy-1,4-dioxonaphthalen-2-yl)-4-methylpent-3-enyl] (Z)-4-(4-methylphenyl)-4-oxobut-2-enoate
   Show/Hide
C27H24O7  1
1
IC50 = 11430 nM
   TI
   LI
   LO
   TS
CP0536839
2,5-diphenyl-[1,3]thiazolo[3,2-b][1,2,4]triazole
   Show/Hide
C16H11N3S  1
1
IC50 = 8300 nM
   TI
   LI
   LO
   TS
CP0538862
4-azido-N-[2-[2-(3-methoxyphenyl)tetrazol-5-yl]phenyl]benzamide
   Show/Hide
C21H16N8O2  2
1
IC50 = 415 nM
   TI
   LI
   LO
   TS
2
IC50 = 20300 nM
   TI
   LI
   LO
   TS
CP0541010
[(8R,9S,10R,13R,14R,17S)-17-[(1S)-1-[(2R)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]-1-hydroxyethyl]-14,17-dihydroxy-10-methyl-1-oxo-2,7,8,9,11,12,15,16-octahydrocyclopenta[a]phenanthren-13-yl]methyl acetate
   Show/Hide
C30H40O8  1
1
IC50 = 3900 nM
   TI
   LI
   LO
   TS
CP0541405
1-[2-[2-(3-methoxyphenyl)tetrazol-5-yl]phenyl]-3-(2-nitrophenyl)urea
   Show/Hide
C21H17N7O4  1
1
IC50 = 222 nM
   TI
   LI
   LO
   TS
CP0552316
N-[4-[(E)-3-(3-methoxyphenyl)prop-2-enoyl]phenyl]-6-methylthieno[2,3-b]quinoline-2-carboxamide
   Show/Hide
C29H22N2O3S  1
1
IC50 = 3600 nM
   TI
   LI
   LO
   TS
CP0565041
(1S,7S,10S,16E,21R)-7-(2-methylpropyl)-21-propan-2-yl-2-oxa-12,13-dithia-5,8,20,23-tetrazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone
   Show/Hide
C23H36N4O6S2  1
1
GI50 = 1100 nM
   TI
   LI
   LO
   TS
CP0569759
5-phenyl-2-(3,4,5-trimethoxyphenyl)-[1,3]thiazolo[3,2-b][1,2,4]triazole
   Show/Hide
C19H17N3O3S  1
1
IC50 = 4800 nM
   TI
   LI
   LO
   TS
CP0572493
N-[4-[2-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]-5-methyl-7-oxopyrido[2,3-d]pyrimidin-8-yl]cyclohexyl]cyclohexanecarboxamide
   Show/Hide
C33H45N7O3  1
1
IC50 = 1090 nM
   TI
   LI
   LO
   TS
CP0633742
2-(4-chloro-3-(methylsulfonamido)phenylamino)-2-methyl-N-(4-(trifluoromethyl)-6H-thiazolo[5,4-e]indazol-2-yl)propanamide
   Show/Hide
C20H18ClF3N6O3S2  1
1
IC50 = 3200 nM
   TI
   LI
   LO
   TS
CP0633747
2-fluoro-5-(2-methyl-1-oxo-1-(4-(trifluoromethyl)-6H-thiazolo[5,4-e]indazol-2-ylamino)propan-2-ylamino)benzamide
   Show/Hide
C20H16F4N6O2S  1
1
IC50 = 1600 nM
   TI
   LI
   LO
   TS
CP0633979
N-ethyl-2-fluoro-5-(2-methyl-1-oxo-1-(4-(trifluoromethyl)-6H-thiazolo[5,4-e]indazol-2-ylamino)propan-2-ylamino)benzamide
   Show/Hide
C22H20F4N6O2S  1
1
IC50 = 1300 nM
   TI
   LI
   LO
   TS
CP0633980
2-methyl-2-(3-sulfamoylphenylamino)-N-(4-(trifluoromethyl)-6H-thiazolo[5,4-e]indazol-2-yl)propanamide
   Show/Hide
C19H17F3N6O3S2  1
1
IC50 = 400 nM
   TI
   LI
   LO
   TS
CP0634033
2-(3-acetamido-4-chlorophenylamino)-2-methyl-N-(4-(trifluoromethyl)-6H-thiazolo[5,4-e]indazol-2-yl)propanamide
   Show/Hide
C21H18ClF3N6O2S  1
1
IC50 = 2400 nM
   TI
   LI
   LO
   TS
CP0634074
2-(4-chlorophenylamino)-3-hydroxy-N-(6H-thiazolo[5,4-e]indazol-2-yl)propanamide
   Show/Hide
C17H14ClN5O2S  1
1
IC50 = 1700 nM
   TI
   LI
   LO
   TS
CP0634075
2-chloro-5-(2-methyl-1-oxo-1-(4-(trifluoromethyl)-6H-thiazolo[5,4-e]indazol-2-ylamino)propan-2-ylamino)benzamide
   Show/Hide
C20H16ClF3N6O2S  1
1
IC50 = 900 nM
   TI
   LI
   LO
   TS
CP0634077
1-(3-hydroxyphenylamino)-N-(6H-thiazolo[5,4-e]indazol-2-yl)cyclopropanecarboxamide
   Show/Hide
C18H15N5O2S  1
1
IC50 = 4000 nM
   TI
   LI
   LO
   TS
CP0634342
2-(3-hydroxyphenylamino)-4-methyl-N-(6H-thiazolo[5,4-e]indazol-2-yl)pentanamide
   Show/Hide
C20H21N5O2S  1
1
IC50 = 3200 nM
   TI
   LI
   LO
   TS
CP0634528
N-(benzyloxy)-2-chloro-5-(2-methyl-1-oxo-1-(4-(trifluoromethyl)-6H-thiazolo[5,4-e]indazol-2-ylamino)propan-2-ylamino)benzamide
   Show/Hide
C27H22ClF3N6O3S  1
1
IC50 = 1800 nM
   TI
   LI
   LO
   TS
CP0634530
1-(3-acetamido-4-fluorophenylamino)-N-(6H-thiazolo[5,4-e]indazol-2-yl)cyclopropanecarboxamide
   Show/Hide
C20H17FN6O2S  1
1
IC50 = 1900 nM
   TI
   LI
   LO
   TS
CP0635002
2-(3-acetamido-4-chlorophenylamino)-2-phenyl-N-(4-(trifluoromethyl)-6H-thiazolo[5,4-e]indazol-2-yl)acetamide
   Show/Hide
C25H18ClF3N6O2S  1
1
IC50 = 4100 nM
   TI
   LI
   LO
   TS
CP0635232
5-(1-(6H-thiazolo[5,4-e]indazol-2-ylcarbamoyl)cyclopropylamino)-2-chloro-N-methylbenzamide
   Show/Hide
C20H17ClN6O2S  1
1
IC50 = 4200 nM
   TI
   LI
   LO
   TS
CP0636016
2-(3-acetamido-4-chlorophenylamino)-2-methyl-N-(6H-thiazolo[5,4-e]indazol-2-yl)propanamide
   Show/Hide
C20H19ClN6O2S  1
1
IC50 = 1100 nM
   TI
   LI
   LO
   TS
CP0645519
ethyl2-amino-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate
   Show/Hide
C17H18N2O5  1
1
GI50 = 156800 nM
   TI
   LI
   LO
   TS
CP0656007
ethyl 2-amino-6-(4-tert-butylphenyl)-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate
   Show/Hide
C27H30N2O5  1
1
GI50 = 160 nM
   TI
   LI
   LO
   TS
CP0846861
6-Aziridin-1-yl-3-hydroxy-7-methyl-1,2,3,4-tetrahydro-cyclopenta[b]indole-5,8-dione
   Show/Hide
C14H14N2O3  2
1
GI50 = 10 nM
   TI
   LI
   LO
   TS
2
LC50 = 100000 nM
   TI
   LI
   LO
   TS
CP0855333
5-Aziridin-1-yl-2,3-bis-hydroxymethyl-6-methyl-1H-indole-4,7-dione
   Show/Hide
C13H14N2O4  2
1
GI50 = 10 nM
   TI
   LI
   LO
   TS
2
LC50 = 1174.9 nM
   TI
   LI
   LO
   TS
CP0879193
3-Acetoxymethyl-5-aziridin-1-yl-4,7-dioxo-4,7-dihydro-1H-indole-2-carboxylic acid ethyl ester
   Show/Hide
C16H16N2O6  1
1
GI50 = 37.15 nM
   TI
   LI
   LO
   TS
CP0881764
Acetic acid 6-aziridin-1-yl-7-methyl-5,8-dioxo-1,2,3,4,5,8-hexahydro-cyclopenta[b]indol-3-yl ester
   Show/Hide
C16H16N2O4  2
1
GI50 = 112.2 nM
   TI
   LI
   LO
   TS
2
LC50 = 1230.27 nM
   TI
   LI
   LO
   TS
CP0881770
7-Aziridin-1-yl-3-hydroxy-6-methyl-1,2,3,4-tetrahydro-cyclopenta[b]indole-5,8-dione
   Show/Hide
C14H14N2O3  1
1
GI50 = 10 nM
   TI
   LI
   LO
   TS
CP0889391
5-Aziridin-1-yl-3-hydroxymethyl-4,7-dioxo-4,7-dihydro-1H-indole-2-carboxylic acid ethyl ester
   Show/Hide
C14H14N2O5  1
1
LC50 = 630.96 nM
   TI
   LI
   LO
   TS
CP0890818
7-Aziridin-1-yl-3-hydroxy-1,2,3,4-tetrahydro-cyclopenta[b]indole-5,8-dione
   Show/Hide
C13H12N2O3  1
1
GI50 = 10 nM
   TI
   LI
   LO
   TS
CP0897002
6-Aziridin-1-yl-3-hydroxy-1,2,3,4-tetrahydro-cyclopenta[b]indole-5,8-dione
   Show/Hide
C13H12N2O3  1
1
LC50 = 1778.28 nM
   TI
   LI
   LO
   TS
CP0899956
6-Aziridin-1-yl-2,3-bis-hydroxymethyl-1H-indole-4,7-dione
   Show/Hide
C12H12N2O4  1
1
GI50 = 138.04 nM
   TI
   LI
   LO
   TS
CP0905159
5-Aziridin-1-yl-3-hydroxymethyl-6-methyl-4,7-dioxo-4,7-dihydro-1H-indole-2-carboxylic acid ethyl ester
   Show/Hide
C15H16N2O5  1
1
GI50 = 10 nM
   TI
   LI
   LO
   TS
CP0911977
N-(4-Methoxyphenyl)-N,2-dimethyl-6,7-dihydro-5H-cyclopenta-[d]pyrimidin-4-aminium Chloride
   Show/Hide
C16H20ClN3O  1
1
GI50 = 10.3 nM
   TI
   LI
   LO
   TS
CP0926275
3-(2-Ethoxyquinolin-6-yl)-1-((1-methylpiperidin-4-yl)-methyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
   Show/Hide
C23H27N7O  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0940704
5-Aziridin-1-yl-2,3-bis-hydroxymethyl-1-methyl-1H-indole-4,7-dione
   Show/Hide
C13H14N2O4  1
1
LC50 = 10 nM
   TI
   LI
   LO
   TS
Protein family and CMB statistics Related to the Cell Line
Cell Lines Derived from the same Tissue Source (Pleural effusion)
Cell Line Name Organism Disease
U-937 Homo sapiens (Human) Adult acute monocytic leukemia
SU-DHL-1 Homo sapiens (Human) Anaplastic large cell lymphoma, ALK-positive
SR Homo sapiens (Human) Anaplastic large cell lymphoma, ALK-positive
MC116 Homo sapiens (Human) B-cell non-Hodgkin lymphoma
K-562 Homo sapiens (Human) Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
K562/A02 Homo sapiens (Human) Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
K562/Adr Homo sapiens (Human) Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
K562/R7 Homo sapiens (Human) Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
K562/DOX Homo sapiens (Human) Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
MDA-MB-231 Homo sapiens (Human) Breast adenocarcinoma
MDA-MB-415 Homo sapiens (Human) Breast adenocarcinoma
MDA-MB-468 Homo sapiens (Human) Breast adenocarcinoma
SK-BR-3 Homo sapiens (Human) Breast adenocarcinoma
AU565 Homo sapiens (Human) Breast adenocarcinoma
CAL-51 Homo sapiens (Human) Breast carcinoma
CAL-120 Homo sapiens (Human) Breast carcinoma
DG-75 Homo sapiens (Human) Burkitt lymphoma
SUP-T1 Homo sapiens (Human) Childhood T lymphoblastic lymphoma
Pfeiffer Homo sapiens (Human) Diffuse large B-cell lymphoma germinal center B-cell type
WSU-DLCL2 Homo sapiens (Human) Diffuse large B-cell lymphoma germinal center B-cell type
Karpas-422 Homo sapiens (Human) Diffuse large B-cell lymphoma germinal center B-cell type
DoHH2 Homo sapiens (Human) Diffuse large B-cell lymphoma germinal center B-cell type
KATO III Homo sapiens (Human) Down syndrome
GIST-T1 Homo sapiens (Human) Gastrointestinal stromal tumor
GIST-5R Homo sapiens (Human) Gastrointestinal stromal tumor
MZ-CRC-1 Homo sapiens (Human) Hereditary thyroid gland medullary carcinoma
L-428 Homo sapiens (Human) Hodgkin lymphoma
KM-H2 Homo sapiens (Human) Hodgkin lymphoma
T-47D Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7/2a Homo sapiens (Human) Invasive breast carcinoma of no special type
T-47 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7 MX100 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7/VP Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7-2a Homo sapiens (Human) Invasive breast carcinoma of no special type
T47D:A18 Homo sapiens (Human) Invasive breast carcinoma of no special type
MVLN Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF/MX Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7/Topo Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7/NOD2 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7aro Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7/MRP1-M6 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7/MRP1-10 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7/MRP1-M24 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7/NOD1 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7piGST Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7-Y1 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7/ADM Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7:WS8 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7-FLV1000 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7-neo/Her2 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7 cl.24 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7/DX1 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7-LC3 Homo sapiens (Human) Invasive breast carcinoma of no special type
T47D-KBluc Homo sapiens (Human) Invasive breast carcinoma of no special type
Calu-6 Homo sapiens (Human) Lung adenocarcinoma
Calu-3 Homo sapiens (Human) Lung adenocarcinoma
HCC78 Homo sapiens (Human) Lung adenocarcinoma
NCI-H3122 Homo sapiens (Human) Lung adenocarcinoma
NCI-H3255 Homo sapiens (Human) Lung adenocarcinoma
NCI-H2122 Homo sapiens (Human) Lung adenocarcinoma
COR-L105 Homo sapiens (Human) Lung adenocarcinoma
NCI-H1437 Homo sapiens (Human) Lung adenocarcinoma
HCC4006 Homo sapiens (Human) Lung adenocarcinoma
NCI-H1792 Homo sapiens (Human) Lung adenocarcinoma
DFCI032 Homo sapiens (Human) Lung adenocarcinoma
NCI-H1355 Homo sapiens (Human) Lung adenocarcinoma
U-1810 Homo sapiens (Human) Lung large cell carcinoma
COR-L23/R Homo sapiens (Human) Lung large cell carcinoma
H460/MX20 Homo sapiens (Human) Lung large cell carcinoma
H460R Homo sapiens (Human) Lung large cell carcinoma
H69AR Homo sapiens (Human) Lung small cell carcinoma
NCI-H69 Homo sapiens (Human) Lung small cell carcinoma
GLC-4/ADR Homo sapiens (Human) Lung small cell carcinoma
STC 1 Homo sapiens (Human) Lung small cell carcinoma
RERF-LC-A1 Homo sapiens (Human) Lung squamous cell carcinoma
Calu-1 Homo sapiens (Human) Lung squamous cell carcinoma
HCC95 Homo sapiens (Human) Lung squamous cell carcinoma
RERF-LC-AI Tet-off Homo sapiens (Human) Lung squamous cell carcinoma
NCI-H1650 Homo sapiens (Human) Minimally invasive lung adenocarcinoma
NCI-H1666 Homo sapiens (Human) Minimally invasive lung adenocarcinoma
NCI-H929 Homo sapiens (Human) Plasma cell myeloma
KMS-11 Homo sapiens (Human) Plasma cell myeloma
UTMC-2 Homo sapiens (Human) Plasma cell myeloma
KMS-12-PE Homo sapiens (Human) Plasma cell myeloma
NCI-H226 Homo sapiens (Human) Pleural epithelioid mesothelioma
Karpas-1106P Homo sapiens (Human) Primary mediastinal (thymic) large B-cell lymphoma